Information about clinical trials provided solely for education and awareness purposes. Patients should consult their medical doctor for advice and recomendations about specific clinical trials. PHEN does not provide medical advice, or recommendations to patients about clinical trials. The clinical trials highlighted are for those organizations who sponsor and support PHEN education and awareness initiatives.

	Introducing Clinical Trials, A PHEN Presentation: An overview of clinical trials emphasizing the importance of African American men participating in prostate cancer clinical trials. This special presentation was webcast at PHEN's July 2011 monthly meeting, hosted at the Dana-Farber Cancer Institute in Boston, Massachusetts. Information		Understanding Clinical Trials, * What is a clinical trial? * Why participate in a clinical trial? * Who can participate in a clinical trial? * What are the benefits and risks of participating in a clinical trial?....And more Information
	Prostate Cancer Clinical Trials, Information providing the purpose, description, eligibility criteria and status for more than 1700 prostate cancer clinical trials/studies in the United States. Information		Entering A Clinical Trial, Is It Right For You?, A Dana-Farber video to assist patients in understanding and making choices about clinical trials. Information
	TrialX, TrialX is a service to help patients find clinical trials that match their health conditions and connect with investigators conducting trials. Information		Medivation, AFFIRM: A Multinational Phase 3 Study of Oral MDV3100 in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy Information
	Millennium, Orteronel (TAK-700): A phase 3 study evaluating orteronel (TAK-700) in the treatment of men with progressive, chemotherapy-naive, metastatic, castration-resistant prostate cancer (mCRPC) Information		The elm•pc004 & elm•pc005 clinical trials, The elm•pc004 clinical research study is seeking men whose prostate cancer has spread to other parts of the body but HAVE NOT received chemotherapy. The elm•pc005 is seeking men who HAVE received chemotherapy. Information
	Cyberknife, Prostate cancer clinical trials for the CyberKnife® Robotic Radiosurgery System - a non-invasive alternative to surgery. Information		BN ImmunoTherapeutics, PROSPECT PROSTVAC® is a therapeutic vaccine candidate in Phase 3 clinical development that has the potential to significantly extend the lives of men with advanced prostate cancer. Information
	Astellas, The PREVAIL Prostate Cancer Clinical Trial: Men whose prostate cancer fits this description may be able to join the PREVAIL Trial: *Your cancer has spread beyond the prostate; *Your cancer has progressed despite hormonal therapy; *Your cancer causes no pain or mild pain; *Your cancer has not been treated with chemotherapy. Information		IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen, The purpose of this study is to show that abiraterone acetate plus prednisone added to the current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate specific antigen (PSA) and prolongs the time until it is evident that the cancer has grown. Information
	SATURN, Pain Reduction Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer Information		US HIFU, Multicenter clinical trial investigating high intensity focused ultrasound (HIFU) with the Sonablate® 500 for locally recurrent prostate cancer following failed EBRT. Information
	PSMA ADC: Metastatic Prostate Cancer Progression After prior Taxane Therapy, Progenics PSMA ADC 1301 - A phase 1 metastatic study of intravenous PSMA ADC in patients with progressive castration-resistant prostate cancer previously treated with two or fewer chemotherapy regimens, one of which includes taxane or a taxane derivative. Information